AMGN compared with GRML: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

GRMLGreenland Mines Ltd

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

GRMLGreenland Mines Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

460.67· pre 485.50· delayed

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

GRMLGreenland Mines Ltd

4.18· pre 4.07· delayed

Pre-marketNov 4 '26delayed

Mkt cap$13.3MRevenue—Revenue—

Compare

Pre-marketNov 4 '26delayed

AMGNAmgen Inc

GRMLGreenland Mines Ltd

460.67pre 485.50delayed

Price

4.18pre 4.07delayed

$249.4B

Mkt cap

$13.3M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN460.67vsGRML4.18Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GRML: latest quarter not drawable.Method ›

Price

rebased to 0%

AMGN, solidGRML, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No disclosed counterparties: GRML.

Only GRML 0

None

Role chip = supplier or customerSource: SEC EDGAR